China Tech Firms at Risk as US Lawmakers Rebuff Lobbying Efforts
- House approves biotech blacklist on fears of Chinese ambitions
- Chinese Drones, EVs, AI and Temu also in lawmakers’ sights
This article is for subscribers only.
US lawmakers are signaling to China that the world’s second-largest economy and its companies face a tough slog in America for the foreseeable future, regardless of who controls Washington after the November election.
At a divisive point in the country’s campaign cycle, House members overcame partisan tensions to vote resoundingly last week to blacklist several Chinese biotech firms from lucrative US-funded research. It was a rare moment of accord that roundly neutralized Chinese lobbying efforts.